ID-EPTRI a new research infrastructure that will facilitate the future development of better paediatric medicines
Roma, January 2018 - ID-EPTRI (European Paediatric Translational Research Infrastructure) is a project coordinated by Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF-TEDDY) [...]
An innovative approach for the patient involvement in the paediatric clinical research: the role of YPAGs
Over the last years, a Europe-wide trend towards a patient-focused approach and the involvement of patients is developing and is influencing the [...]
ICH-GOOD CLINICAL PRACTICE (GCP) TRAINING COURSE
The e-learning “ICH-Good Clinical Practice (GCP) Training Course”, promoted by Consorzio per Valutazioni Biologiche e Farmacologiche in the framework of the GAPP [...]
The pilot study QuBo was presented at the 14th International Conference on Thalassaemia & Haemoglobinopathies and 16th TIF International Conference for Patients & Parents
From November 17th to 19th, 2017, the 14th International Conference on Thalassaemia & Haemoglobinopathies and the 16th TIF International Conference for Patients [...]
EMA: Brexit update and adoption of work programme for 2018
The last press release published by EMA (European Medicines Agency) on December 15th, 2017, reports some important highlights from the Management Board [...]
Launch of the Parliamentary Advocates for Rare Diseases
On October 17th, 2017, the Parliamentary Advocates for Rare Diseases, a network of European and national members of Parliament advocating to improve [...]